Microrna-181 Inhibitor Protects Against Sevoflurane-Induced Hippocampal Apoptosis And Memory Impairment

Jun Chen,Zhihua Jiao,Aizhong Wang,Wenhui Zhong,Binying Liu,Ning Gan
2016-01-01
Abstract:We aimed to investigate whether miR-181 was associated with sevoflurane-induced neurodegeneration, as well as to elucidate the potential regulatory mechanism of miR-181 in hippocampus. We established a model by administering 2% sevoflurane into rats from 9: 00 AM to 3: 00 PM. We then conducted quantitative real-time polymerase chain reaction (qRT-PCR) to determine the expression of miR-181. We then used lentivirual tools to down-regulate the expression of miR-181 in hippocampus, and discovered the effect of miR-181 inhibition on sevoflurane-induced hippocampal function and apoptosis after sevoflurane exposure using Morris water maze and hippocampal terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining. Besides, the expression levels of PSD95, total CREB and p-CREB were determined by western blot. miR-181 was significantly upregulated in hippocampus following general anesthesia by sevoflrane. In addition, sevoflrane could induce hippocampal apoptosis and memory impairment, and miR-181 inhibition could alleviate these negative effects induced by sevoflrane to some extent. Besides, miR-181 inhibition increased the expression of PSD95 and p-CREB/CREB that was significant decreased after sevoflrane exposure in hippocampus. Our findings indicate that miR-181 negatively modulated sevoflrane-induced hippocampal apoptosis and memory impairment possibly through regulating the levels of PSD95 and p-CREB/CREB ratio. MiR-181 inhibitor may effectively protect against sevoflurane-induced hippocampal impairments.
What problem does this paper attempt to address?